147 related articles for article (PubMed ID: 38808237)
1. Novel carbazolyl-thiazolyl-chromone and carbazolyl-thiazolyl-pyrazole hybrids: synthesis, cytotoxicity evaluation and molecular docking studies.
Hassanin NM; Ali TE; Assiri MA; Abdel-Kariem SM
RSC Adv; 2024 May; 14(24):17245-17260. PubMed ID: 38808237
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents.
Saeed A; Soliman AM; Abdullah MMS; Abdel-Latif E; El-Demerdash A
Chem Biodivers; 2024 Mar; ():e202301870. PubMed ID: 38538544
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel (
Riadi Y; Afzal O; Kumar S; Varadharajan V; Geesi MH
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38523573
[TBL] [Abstract][Full Text] [Related]
6. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
[TBL] [Abstract][Full Text] [Related]
7. Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents.
Sayed AR; Gomha SM; Abdelrazek FM; Farghaly MS; Hassan SA; Metz P
BMC Chem; 2019 Dec; 13(1):116. PubMed ID: 31572983
[TBL] [Abstract][Full Text] [Related]
8. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
9. Recyclization of morpholinochromonylidene-thiazolidinone using nucleophiles: facile synthesis, cytotoxic evaluation, apoptosis, cell cycle and molecular docking studies of a novel series of azole, azine, azepine and pyran derivatives.
Ali TE; Assiri MA; Alqahtani MN; Shati AA; Alfaifi MY; Elbehairi SEI
RSC Adv; 2023 Jun; 13(27):18658-18675. PubMed ID: 37346943
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
El-Adl K; El-Helby AA; Sakr H; Eissa IH; El-Hddad SSA; M I A Shoman F
Bioorg Chem; 2020 Sep; 102():104059. PubMed ID: 32653608
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
13. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Adl K; Sakr H; Nasser M; Alswah M; Shoman FMA
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000079. PubMed ID: 32515896
[TBL] [Abstract][Full Text] [Related]
14. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
15. Ionic Liquid-Catalyzed Green Protocol for Multi-Component Synthesis of Dihydropyrano[2,3-c]pyrazoles as Potential Anticancer Scaffolds.
Nimbalkar UD; Seijas JA; Vazquez-Tato MP; Damale MG; Sangshetti JN; Nikalje APG
Molecules; 2017 Sep; 22(10):. PubMed ID: 28956863
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
17. Novel Pyran-Linked Phthalazinone-Pyrazole Hybrids: Synthesis, Cytotoxicity Evaluation, Molecular Modeling, and Descriptor Studies.
Malik MS; Asghar BH; Syed R; Alsantali RI; Morad M; Altass HM; Moussa Z; Althagafi II; Jassas RS; Ahmed SA
Front Chem; 2021; 9():666573. PubMed ID: 34109154
[TBL] [Abstract][Full Text] [Related]
18. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
19. Novel Thiopyrano[2,3-
Metwally NH; El-Desoky EA
ACS Omega; 2023 Feb; 8(6):5571-5592. PubMed ID: 36816682
[TBL] [Abstract][Full Text] [Related]
20. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA.
Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A
Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
